NHAS
ZSPH

Novo Holdings A/S’s ZS PHARMA INC COMS TK (DE) ZSPH Stock Holding History

Novo Holdings A/S’s Portfolio ZSPH Stock Details ZSPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-506,730
Closed -$19.9M – 16
2014
Q3 		$19.9M Buy
+506,730
New +$16.7M 1.94% 9

Other funds holding ZSPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DPA
Devon Park Associates $30.8M AUM 0.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Novo Holdings A/S's ZSPH Position: Q4 2014 in Review

Novo Holdings A/S sold out of ZS PHARMA INC COMS TK (DE) (ZSPH) in Q4 2014, closing a stake of 506,730 shares — an estimated $19.9M sold.

Novo Holdings A/S first reported a position in ZSPH in Q3 2014 and held it in 1 quarter. The position peaked at $19.9M in Q3 2014. 78 funds tracked by Wall St. Rank hold ZSPH as of Q4 2014.

  • Novo Holdings A/S reported no remaining ZS PHARMA INC COMS TK (DE) position as of Q4 2014 after selling out during the quarter.
  • Novo Holdings A/S sold 506,730 ZS PHARMA INC COMS TK (DE) shares in Q4 2014, an estimated $19.9M.
  • Novo Holdings A/S first reported a position in ZS PHARMA INC COMS TK (DE) in Q3 2014 and held it in 1 quarter.
  • Novo Holdings A/S's ZS PHARMA INC COMS TK (DE) position peaked at $19.9M in Q3 2014.
  • 78 funds tracked by Wall St. Rank held ZS PHARMA INC COMS TK (DE) as of Q4 2014.

Based on Novo Holdings A/S's 13F filing for Q4 2014, filed 17 Feb 2015.